ABEO
HEALTHCAREAbeona Therapeutics Inc
$6.01+0.18 (+3.09%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ABEO Today?
No stock-specific AI insight has been generated for ABEO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$4.00$7.54
$6.01
Fundamentals
Market Cap$342M
P/E Ratio6.0
EPS$1.01
Dividend Yield—
Dividend / Share—
ROE0.7%
Profit Margin12.2%
Debt / Equity—
Trading
Volume1.8M
Avg Volume (10D)—
Shares Outstanding56.9M
ABEO News
20 articles- High Insider Ownership Boosts These Growth Stocks In May 2026Yahoo Finance·May 8, 2026
- May 2026's Top Growth Companies With Insider InfluenceYahoo Finance·May 8, 2026
- Abeona Therapeutics® Announces Date of First Quarter Financial ResultsYahoo Finance·May 4, 2026
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·May 1, 2026
- Spotlighting Abeona Therapeutics And 2 More High Growth Stocks Insiders FavorYahoo Finance·Apr 21, 2026
- Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of DirectorsYahoo Finance·Apr 7, 2026
- Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New YorkYahoo Finance·Apr 2, 2026
- Abeona Therapeutics Inc. Q4 2025 Earnings Call SummaryMoby·Mar 20, 2026
- ABEO: Momentum Building for Zevaskyn®Yahoo Finance·Mar 18, 2026
- Abeona Therapeutics Inc (ABEO) Q4 2025 Earnings Call Highlights: Strong Demand for Zivasskin ...Yahoo Finance·Mar 17, 2026
- Abeona Therapeutics Q4 Earnings Call HighlightsMarketbeat·Mar 17, 2026
- Abeona (ABEO) Q4 2025 Earnings Call TranscriptMotley Fool·Mar 17, 2026
- Abeona Therapeutics: Q4 Earnings SnapshotYahoo Finance·Mar 17, 2026
- Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate UpdatesYahoo Finance·Mar 17, 2026
- Abeona Therapeutics Says ZEVASKYN Launch Is Back on Track, Eyes Profitability in 2026Marketbeat·Mar 10, 2026
- Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial LaunchYahoo Finance·Mar 9, 2026
- Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare ConferenceYahoo Finance·Mar 3, 2026
- Netflix Is Casting a Light on a Rare Disease. Pearl Jam’s Frontman Is Raising Cash to Cure It.Yahoo Finance·Feb 14, 2026
- Insider-Favored Growth Companies To Watch February 2026Yahoo Finance·Feb 2, 2026
- 3 Insider-Owned Growth Stocks For Your WatchlistYahoo Finance·Jan 1, 2026
All 20 articles loaded
Price Data
Open$5.89
Previous Close$5.83
Day High$6.07
Day Low$5.83
52 Week High$7.54
52 Week Low$4.00
52-Week Range
$4.00$7.54
$6.01
Fundamentals
Market Cap$342M
P/E Ratio6.0
EPS$1.01
Dividend Yield—
Dividend / Share—
ROE0.7%
Profit Margin12.2%
Debt / Equity—
Trading
Volume1.8M
Avg Volume (10D)—
Shares Outstanding56.9M
About Abeona Therapeutics Inc
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for rare, life-threatening genetic diseases. The company is headquartered in New York, New York.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—